ASCO 2024 | Overview of managing CNS metastases in pediatric Ewing sarcoma

Leonora Slatnick • 1 Jun 2024

ASCO 2024

Sarcoma

Leonora Slatnick, MD, University of Utah, Salt Lake City, UT, provides an overview of managing central nervous system (CNS) metastases in pediatric patients with Ewing sarcoma (ES). The lack of standardized management and the poor outcomes for these patients are highlighted. Although outcomes may differ from other metastatic or relapsed diseases, the small cohort size makes it unclear. One case involved a patient with incomplete resection who underwent high-dose chemotherapy with stem cell rescue and achieved long-term survival, which is unusual. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.